Qiagen N.V. (QGEN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 39.23 |
| Open | 39.31 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 39.03 - 39.56 |
| 52 Week Range | 34.74 - 47.70 |
| Volume | |
| Avg. Volume | 1,020,446 |
| Market Cap | 8.737B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 25.80 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.28 (2.94%) |
| Ex-Dividend Date | Jan 30, 2024 |
| 1y Target Est | N/A |
- Zacks
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
- Zacks
QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
With QIAGEN's (QGEN) QIAstat-Dx Analyzer 2.0's integration of remote access, central and regional laboratories may work together efficiently, particularly when it comes to decentralized testing.
- Zacks
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
© 2024 Yahoo. All rights reserved.